Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fimmu.2020.01446 http://scihub22266oqcxt.onion/10.3389/fimmu.2020.01446 C7308649!7308649 !32612617     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32612617 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Front+Immunol 2020 ; 11 (ä): 1446 Nephropedia Template TP {{tp|p=32612617 |t=2020. The COVID-19 Cytokine Storm; What We Know So Far |pdf=|usr=}}{{32612617 }} gab.com Text The COVID-19 Cytokine Storm; What We Know So Far JO: Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32612617 #FOAvip COVID-19 is a rapidly spreading global threat that has been declared as a pandemic by the WHO. COVID-19 is transmitted via droplets or direct contact and infects the respiratory tract resulting in pneumonia in most of the cases and acute respiratory distress syndrome (ARDS) in about 15 % of the cases. Mortality in COVID-19 patients has been linked to the presence of the so-called "cytokine storm" induced by the virus. Excessive production of proinflammatory cytokines leads to ARDS aggravation and widespread tissue damage resulting in multi-organ failure and death. Targeting cytokines during the management of COVID-19 patients could improve survival rates and reduce mortality. Twit Text FOAVip The COVID-19 Cytokine Storm; What We Know So Far ????Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32612617 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32612617 #FOAvip English Wikipedia <ref>{{Cite pmid|32612617 }}</ref> The COVID-19 Cytokine Storm; What We Know So Far #MMPMID32612617 Ragab D ; Salah Eldin H ; Taeimah M ; Khattab R ; Salem R Front Immunol 2020[]; 11 (ä): 1446 PMID32612617 show ga COVID-19 is a rapidly spreading global threat that has been declared as a pandemic by the WHO. COVID-19 is transmitted via droplets or direct contact and infects the respiratory tract resulting in pneumonia in most of the cases and acute respiratory distress syndrome (ARDS) in about 15 % of the cases. Mortality in COVID-19 patients has been linked to the presence of the so-called "cytokine storm" induced by the virus. Excessive production of proinflammatory cytokines leads to ARDS aggravation and widespread tissue damage resulting in multi-organ failure and death. Targeting cytokines during the management of COVID-19 patients could improve survival rates and reduce mortality. |Antibodies, Monoclonal, Humanized/therapeutic use [MESH] |Betacoronavirus/immunology [MESH] |COVID-19 [MESH] |COVID-19 Drug Treatment [MESH] |Coronavirus Infections/*drug therapy/immunology/*pathology [MESH] |Cytokine Release Syndrome/*drug therapy/immunology/*pathology [MESH] |Cytokines/blood [MESH] |Humans [MESH] |Interleukin-6/antagonists & inhibitors [MESH] |Pandemics [MESH] |Pneumonia, Viral/*drug therapy/immunology/*pathology [MESH] |Receptors, Interleukin-6/antagonists & inhibitors [MESH] |Respiratory Distress Syndrome/drug therapy/pathology/*prevention & control [MESH]The COVID-19 Cytokine Storm; What We Know So Far (epmc).pdf DeepDyve Pubget Overpricing